Skip to main content

Fiscal Wizard · Single-issue tearsheet

HUM / Jun 21, 2026 Run #7419

HUM

Humana Inc.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Composite verdict

B 61.7 / 100
Bullish setup · Mean Reversion 6 drivers · 2 gates blocking
  • Double 7s
  • Rate of Change
  • Relative Strength vs SPY
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 5th of 11 in Healthcare Plans

rescore-sweep
Technical synthesisRegime: uptrend
Bull 100%Evidence: High · 21 signals0% Bear
Momentum Bullish 94Mean-reversion Neutral 56
  • Pullback buyOversold in an uptrend — a pullback buy: mean-reversion aligned with the primary trend, the high-value case for an oversold signal. (medium confidence)
Where value comes fromMargin of safety -58%
Asset value $147.07Earnings power value $141.97Price $360.65

Priced above its no-growth earnings power value ($141.97/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Weak

23.4 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Days Sales Outstanding 100
Margin of Safety 0
Payout Ratio 89
EV/FCF 0
Capex to Sales 75
Free Cash Flow Yield 0

Technicals Bullish

100.0 / 100

Bullish setup leads (Double 7s, Rate of Change, Relative Strength vs SPY); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Double 7s 88
Rate of Change 83
Relative Strength vs SPY 71

Risk Gates

2 blocking 5 caution

2 guards active, 19 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Interest Coverage Caution

Weak interest coverage blocks bullish signals — debt-service risk.

LT Debt-to-Equity Caution

High long-term D/E blocks bullish signals — structural-leverage risk.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for HUM.